Form 8-K - Current report:
SEC Accession No. 0001654954-25-002385
Filing Date
2025-03-06
Accepted
2025-03-06 17:00:30
Documents
23
Period of Report
2025-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tenx_8k.htm   iXBRL 8-K 39223
2 FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK tenx_ex41.htm EX-4.1 89500
3 FORM OF SECURITIES PURCHASE AGREEMENT tenx_ex101.htm EX-10.1 209659
4 FORM OF REGISTRATION RIGHTS AGREEMENT tenx_ex102.htm EX-10.2 124069
5 PRESS RELEASE tenx_ex991.htm EX-99.1 7628
6 PRESS RELEASE tenx_ex992.htm EX-99.2 17963
12 tenx_ex992img1.jpg GRAPHIC 3600
13 tenx_ex992img2.jpg GRAPHIC 3600
14 tenx_ex991img2.jpg GRAPHIC 4927
  Complete submission text file 0001654954-25-002385.txt   743600

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA tenx-20250304.xsd EX-101.SCH 5874
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tenx-20250304_lab.xml EX-101.LAB 14667
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tenx-20250304_cal.xml EX-101.CAL 898
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tenx-20250304_pre.xml EX-101.PRE 9275
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tenx-20250304_def.xml EX-101.DEF 2099
25 EXTRACTED XBRL INSTANCE DOCUMENT tenx_8k_htm.xml XML 3910
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34600 | Film No.: 25716163
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)